Current evidence indicates that although AMH has emerged as a promising biomarker, its predictive value is not definitive and may be affected by various factors, including the underlying etiology of azoospermia, the presence of genetic abnormalities, and interactions with other Sertoli cell products such as inhibin B [1,11]. The gene discussed is AMH; the disease is Azoospermia.